Research progress on glucose-regulated protein 78 in drug resistance and targeted therapy for cancer

郑以孜; 邵志敏

doi:10.19401/j.cnki.1007-3639.2018.02.013

您当前的位置：

首页 >

文章列表页 >

Research progress on glucose-regulated protein 78 in drug resistance and targeted therapy for cancer

更新时间：2026-01-27

- Research progress on glucose-regulated protein 78 in drug resistance and targeted therapy for cancer
- China Oncology Vol. 28, Issue 2, Pages: 156-160(2018)
- 作者机构：
  
  复旦大学附属肿瘤医院乳腺外科，复旦大学上海医学院肿瘤学系,上海,200032
- 作者简介：
- 基金信息：
- DOI：10.19401/j.cnki.1007-3639.2018.02.013
  CLC： R730.5
- Published Online：08 March 2018，
  
  Published：08 March 2018
- 稿件说明：
移动端阅览
郑以孜,邵志敏. 葡萄糖调节蛋白78与肿瘤耐药和靶向治疗进展[J]. 中国癌症杂志, 2018, 28(2): 156-160.

郑以孜, 邵志敏. Research progress on glucose-regulated protein 78 in drug resistance and targeted therapy for cancer[J]. China Oncology, 2018, 28(2): 156-160.
郑以孜,邵志敏. 葡萄糖调节蛋白78与肿瘤耐药和靶向治疗进展[J]. 中国癌症杂志, 2018, 28(2): 156-160. DOI： 10.19401/j.cnki.1007-3639.2018.02.013.

郑以孜, 邵志敏. Research progress on glucose-regulated protein 78 in drug resistance and targeted therapy for cancer[J]. China Oncology, 2018, 28(2): 156-160. DOI： 10.19401/j.cnki.1007-3639.2018.02.013.

摘要

葡萄糖调节蛋白78(glucose-regulated protein 78，GRP78)在肿瘤耐药发生中具有重要作用，针对GRP78的靶向治疗已成为抗癌治疗的研究热点。该研究简要介绍了葡萄糖调节蛋白78，总结其与化疗、内分泌治疗、靶向治疗等治疗耐药的关系以及耐药机制，同时总结了GRP78靶向治疗方面的研究进展。

Abstract

Glucose-regulated protein 78 (GRP78) plays an important role in the development of drug resistance in cancer

and GRP78 targeted therapy has become a hotspot of cancer research. In this article

we briefly introduce GRP78

review the research progress on the roles of GRP78 in drug resistance to cancer therapies

including chemotherapy

endocrine therapy and targeted therapy

and the mechanisms of resistance. The progress on GRP78 targeted therapy for cancer is also summarized.

关键词

Keywords

references

Views

4505

下载量

CSCD

Alert me when the article has been cited

提交

Tools

Publicity Resources

Progress and prospects of CENPA-driven chromosomal instability in breast cancer: mechanisms, prognostic implications, and therapeutic perspectives

Targeted therapy and immunotherapy combined with chemotherapy bring effective response to AFP positive colon cancer patients: a case report and literature review

Research status and progress of third-line treatment for metastatic colorectal cancer

Effectiveness and safety analysis of camrelizumab combined with chemotherapy and targeted therapy in patients with recurrent, metastatic, and treatment-naive advanced cervical cancer: a retrospective cohort study

A research on the mechanism of SERPINA3 promoting malignant progression and gemcitabine resistance of pancreatic cancer by inhibiting ferroptosis

Related Author

LU Ye

ZHANG Wenxiang

KONG Xiangyi

FANG Yi

WANG Jing

GAO Jidong

LIU Miao

LI Jinze

Related Institution

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Breast Surgery, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital& Shenzhen Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College

Department of Pathology, the Fourth Hospital of Hebei Medical University

Department of Gastroenterology, the Fourth Hospital of Hebei Medical University

Department of Oncology, The First Affiliated Hospital of Naval Medical University

AI问答

⁰